| Working Paper |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| A G2 for science? |
0 |
0 |
0 |
14 |
1 |
2 |
4 |
102 |
| A lifeline for Europe's young radical innovators |
0 |
0 |
0 |
24 |
0 |
1 |
4 |
177 |
| Acquiring R&D Projects: Who, When, and What? Evidence from Antidiabetic Drug Development |
1 |
1 |
2 |
12 |
5 |
6 |
14 |
25 |
| Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development |
0 |
0 |
1 |
1 |
3 |
3 |
8 |
10 |
| Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development |
0 |
0 |
3 |
16 |
2 |
3 |
8 |
19 |
| Alliances and the Pattern of Comparative Advantages: a Sectoral Analysis |
0 |
0 |
0 |
2 |
0 |
2 |
3 |
5 |
| An empirical analysis of strategic price setting in the Belgian leasing market |
0 |
0 |
0 |
5 |
0 |
0 |
0 |
33 |
| Are European firms falling behind in the global corporate research race? |
0 |
0 |
2 |
54 |
1 |
1 |
7 |
73 |
| Are M&As Spurring or Stifling Innovation? Evidence from Antidiabetic Drug Development |
1 |
1 |
27 |
27 |
4 |
5 |
41 |
41 |
| Are M&As spurring or stifling innovation? Evidence from antidiabetic drug development |
0 |
1 |
12 |
12 |
4 |
6 |
10 |
10 |
| Are external technology sourcing strategies substitutes or complements? The case of embodied versus disembodied technology acquisition |
0 |
0 |
0 |
267 |
1 |
2 |
3 |
802 |
| Assessing the Foreign Control of Production of Technology: The Case of a Small Open Economy |
0 |
0 |
0 |
96 |
3 |
5 |
7 |
487 |
| Assessing the foreign control of production of technology: The case of a small open economy |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
45 |
| Assessing the potential for knowledge-based development in transition countries |
0 |
0 |
0 |
41 |
0 |
0 |
1 |
78 |
| Beyond Citations: Measuring Novel Scientific Ideas and their Impact in Publication Text |
0 |
0 |
5 |
40 |
8 |
12 |
45 |
116 |
| Beyond citations: Measuring novel scientific ideas and their impact in publication text |
1 |
1 |
20 |
20 |
6 |
10 |
28 |
28 |
| Bias against Novelty in Science: A Cautionary Tale for Users of Bibliometric Indicators |
0 |
0 |
0 |
35 |
3 |
6 |
6 |
64 |
| Bias against Novelty in Science: A Cautionary Tale for Users of Bibliometric Indicators |
0 |
0 |
0 |
34 |
4 |
5 |
10 |
124 |
| Bias against novelty in science: A cautionary tale for users of bibliometric indicators |
0 |
0 |
1 |
7 |
3 |
5 |
10 |
70 |
| Boosting innovation in Europe |
0 |
0 |
1 |
76 |
0 |
3 |
9 |
201 |
| Boosting innovation in Europe |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
47 |
| Bridging the divide- new evidence about firms and digitalisation |
0 |
0 |
0 |
15 |
0 |
4 |
8 |
63 |
| Climate-related innovations, crowding out, and their impact on competitiveness |
0 |
0 |
0 |
28 |
1 |
3 |
3 |
50 |
| Cold Start for the Green Innovation Machine |
0 |
0 |
0 |
69 |
6 |
12 |
17 |
271 |
| Complementarity between technology make and buy in innovation strategies: Evidence from Belgiam manufacturing firms |
0 |
0 |
0 |
645 |
3 |
4 |
9 |
2,532 |
| Complementarity in the Innovation Strategy: Internal R&D, External Technology Acquisition and Cooperation |
0 |
0 |
3 |
637 |
9 |
9 |
22 |
2,552 |
| Complementarity in the innovation strategy: Internal R&D, external technology acquisition, and cooperation in R&D |
0 |
0 |
1 |
606 |
4 |
6 |
8 |
1,551 |
| Corporate structure of leading firms in Europe: does country origin still matter? |
0 |
0 |
0 |
149 |
1 |
5 |
6 |
568 |
| Designing Contracts for University Spin-offs |
0 |
0 |
0 |
34 |
0 |
2 |
6 |
145 |
| Differences in the rates of return to R&D for European and US young leading R&D firms |
0 |
0 |
0 |
46 |
3 |
9 |
10 |
83 |
| Direct and Cross-Scheme Effects in a Research and Development Subsidy Program |
0 |
1 |
1 |
27 |
0 |
2 |
2 |
54 |
| Direct and Cross-Scheme Effects in a Research and Development Subsidy Program |
0 |
0 |
0 |
18 |
1 |
5 |
8 |
69 |
| Direct and cross scheme effects in R&D subsidy programs |
0 |
1 |
1 |
4 |
1 |
4 |
8 |
26 |
| Direct and cross-scheme effects in a research and development subsidy program |
0 |
0 |
0 |
70 |
3 |
4 |
4 |
173 |
| Direct and cross-scheme effects in a research and development subsidy program |
0 |
0 |
0 |
35 |
0 |
3 |
3 |
54 |
| Directionality in R&I Policy: A methodology to assess practices in the EU Member States and Associated Countries |
3 |
8 |
8 |
8 |
3 |
4 |
4 |
4 |
| Diversity of science linkages and innovation performance: some empirical evidence from Flemish firms |
0 |
0 |
0 |
73 |
1 |
3 |
15 |
362 |
| Do Funding Agencies Select and Enable Risky Research: Evidence from ERC Using Novelty as a Proxy of Risk Taking |
0 |
0 |
2 |
26 |
3 |
4 |
10 |
59 |
| Do funding agencies select and enable risky research: Evidence from ERC using novelty as a proxy of risk taking |
0 |
0 |
1 |
4 |
4 |
6 |
10 |
31 |
| Does university quality drive international student flows? |
0 |
0 |
0 |
96 |
2 |
4 |
8 |
302 |
| Dynamische effecten in industriële organisaties |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
| Eco‐systems for young digital innovators |
0 |
0 |
0 |
67 |
2 |
4 |
4 |
51 |
| Een schets van Belgische ondernemingen in allianties |
0 |
0 |
0 |
3 |
0 |
1 |
1 |
13 |
| Endogeneizing know-how flows through the nature of R&D investments |
0 |
0 |
0 |
141 |
3 |
3 |
5 |
521 |
| Endogeneizing know-how flows through the nature of R&D investments |
0 |
0 |
0 |
210 |
4 |
7 |
9 |
662 |
| Endogenizing Know-How Flows Through the Nature of R&D Investments |
0 |
0 |
0 |
67 |
0 |
4 |
6 |
326 |
| Europe's clean technology investment challenge |
0 |
0 |
0 |
34 |
0 |
0 |
2 |
94 |
| Europe's missing yollies |
0 |
0 |
0 |
68 |
1 |
2 |
4 |
259 |
| European Anti-dumping Policy and the Profitability of National and International Collusion |
0 |
0 |
0 |
230 |
2 |
5 |
6 |
855 |
| European anti-dumping policy and the profitability of national and international collusion |
0 |
0 |
0 |
9 |
4 |
4 |
5 |
59 |
| Europe’s missing Yollies |
0 |
0 |
0 |
0 |
0 |
2 |
2 |
95 |
| Exploring Europe's R&D deficit relative to the US: Differences in the rates of return to R&D of young leading R&D firms |
0 |
0 |
0 |
16 |
1 |
2 |
2 |
59 |
| External technology sources: Embodied or disembodied technology acquisition |
0 |
0 |
0 |
592 |
2 |
4 |
7 |
2,262 |
| Financing EU Health Innovation: the role of Venture Capital |
0 |
2 |
16 |
16 |
1 |
5 |
34 |
34 |
| Foreign subsidiaries as channel of international technology diffusion. Some direct firm level evidence from Belgium |
0 |
0 |
1 |
201 |
0 |
0 |
3 |
843 |
| Funding Risky Research |
0 |
0 |
1 |
25 |
0 |
3 |
7 |
39 |
| Getting the most from public R&D spending in times of budgetary austerity |
0 |
0 |
1 |
63 |
2 |
6 |
8 |
104 |
| Green innovations and organisational change: making better use of environmental technology |
0 |
0 |
0 |
66 |
2 |
8 |
12 |
184 |
| Green innovations and organizational change: Making better use of environmental technology |
0 |
0 |
0 |
71 |
2 |
2 |
3 |
105 |
| Green innovations and organizational change: Making better use of environmental technology |
0 |
0 |
0 |
34 |
1 |
5 |
8 |
163 |
| Handle with care! Post-crisis growth in the EU |
0 |
0 |
0 |
118 |
2 |
2 |
3 |
281 |
| Heterogeneity in R&D Cooperation Strategies |
1 |
1 |
1 |
309 |
1 |
6 |
10 |
901 |
| Higher Education Reform and the Renewed Lisbon Strategy: Role of Member States and the European Commission |
0 |
0 |
0 |
135 |
0 |
3 |
3 |
483 |
| Higher Education Reform and the Renewed Lisbon Strategy: Role of Member States and the European Commission |
0 |
0 |
1 |
162 |
2 |
3 |
5 |
521 |
| How Europe should answer the US Inflation Reduction Act |
0 |
0 |
0 |
0 |
4 |
6 |
11 |
26 |
| How fast is this novel technology going to be a hit? |
0 |
0 |
0 |
79 |
4 |
7 |
9 |
234 |
| How fast is this novel technology going to be a hit? Antecedents predicting follow-on inventions |
0 |
0 |
0 |
1 |
1 |
2 |
3 |
14 |
| How fast is this novel technology going to be a hit? Antecedents predicting follow-on inventions |
0 |
0 |
0 |
38 |
1 |
3 |
6 |
54 |
| Impact of M&A on the R&D process. An empirical analysis of the role of technological and market relatedness, The |
0 |
0 |
6 |
441 |
1 |
6 |
27 |
1,506 |
| Importance of International Linkages for Local Know-How Flows: Some Econometric Evidence From Belgium |
0 |
0 |
0 |
73 |
2 |
4 |
8 |
505 |
| Importance of international linkages for local know-how flows. Some econometric evidence from Belgium |
0 |
0 |
0 |
249 |
2 |
3 |
4 |
1,861 |
| Innovation in EU merger control- walking the talk |
0 |
0 |
3 |
179 |
0 |
4 |
9 |
245 |
| Innovative strategic groups in multinational industries |
0 |
0 |
0 |
2 |
1 |
2 |
2 |
9 |
| Is This Novel Technology Going to be a Hit? Antecedents Predicting Technological Novelty Diffusion |
0 |
0 |
0 |
50 |
2 |
5 |
7 |
172 |
| Is the European automotive industry ready for the global electric vehicle revolution? |
0 |
1 |
3 |
71 |
6 |
7 |
20 |
152 |
| Lessons for ICT Innovative Industries: Three Experts Positions on Financing, IPR and Industrial Ecosystems |
0 |
0 |
1 |
48 |
2 |
2 |
5 |
160 |
| Licensing of University Inventions: The Role of a Technology Transfer Office |
0 |
0 |
0 |
66 |
3 |
4 |
4 |
277 |
| Locational determinats and ranking of host countries: an empirical assessment |
0 |
0 |
0 |
0 |
1 |
2 |
2 |
7 |
| Market Integration and Technological Leadership in Europe |
0 |
0 |
0 |
115 |
3 |
8 |
12 |
273 |
| Matching research and innovation policies in EU countries |
0 |
0 |
1 |
1 |
0 |
0 |
1 |
5 |
| Matching research and innovation policies in EU countries |
0 |
0 |
0 |
68 |
1 |
1 |
5 |
69 |
| Measuring technological novelty with patent-based indicators |
1 |
2 |
3 |
44 |
11 |
18 |
33 |
189 |
| Memo to the New Digital Agenda Commissioner |
0 |
0 |
0 |
43 |
0 |
0 |
0 |
124 |
| Mind Europe's early-stage equity gap |
0 |
0 |
0 |
57 |
1 |
2 |
3 |
123 |
| Mind the Gap: Capturing Value From Basic Research. Boundary crossing inventors and partnerships |
0 |
0 |
1 |
18 |
0 |
1 |
3 |
62 |
| Mind the gap: capturing value from basic research: boundary crossing inventors and partnerships |
0 |
0 |
0 |
67 |
3 |
4 |
9 |
148 |
| Missing Convergence in Innovation Capacity in the EU: Facts and Policy Implications |
0 |
2 |
4 |
86 |
3 |
10 |
16 |
148 |
| Multinational Knowledge Spillovers with Centralized versus Decentralized R&D: A Game Theoretic Approach |
0 |
0 |
0 |
402 |
1 |
2 |
4 |
1,842 |
| New ICT sectors- Platforms for European growth? |
0 |
0 |
0 |
25 |
2 |
3 |
4 |
73 |
| No green growth without innovation |
0 |
1 |
5 |
528 |
3 |
7 |
22 |
1,425 |
| No green growth without innovation |
0 |
0 |
0 |
0 |
2 |
6 |
6 |
6 |
| Not like the others: frontier scientists for high-impact inventions |
0 |
0 |
0 |
24 |
3 |
5 |
7 |
49 |
| Novel science for industry? |
0 |
0 |
0 |
1 |
0 |
0 |
2 |
22 |
| Off the beaten path: What drives scientists’ entry into new fields? |
0 |
0 |
0 |
11 |
1 |
1 |
3 |
30 |
| On Young Innovative Companies: Why they matter and how (not) to policy support them |
0 |
0 |
0 |
113 |
1 |
2 |
4 |
291 |
| Organisational change and the productivity effects of green technology adoption |
0 |
0 |
2 |
75 |
0 |
2 |
7 |
223 |
| Powering the clean energy innovation system |
0 |
0 |
1 |
16 |
3 |
5 |
12 |
30 |
| R&D Cooperation Between Firms and Universities: Some Empirical Evidence from Belgian Manufacturing |
0 |
0 |
0 |
271 |
1 |
7 |
14 |
1,019 |
| R&D Cooperation and Spillovers: Some Empirical Evidence |
0 |
0 |
2 |
123 |
1 |
5 |
15 |
532 |
| R&D Financing Constraints of Young and Old Innovation Leaders in the EU and the US |
0 |
0 |
0 |
49 |
2 |
6 |
7 |
164 |
| R&D activities of the business sector in Flanders: results of the R&D surveys in the context of the 3% target |
0 |
0 |
0 |
4 |
0 |
0 |
0 |
30 |
| R&D cooperation and spillovers: Some empirical evidence |
0 |
0 |
0 |
261 |
3 |
7 |
8 |
700 |
| R&D cooperation and spillovers: Some empirical evidence |
0 |
0 |
0 |
430 |
1 |
1 |
7 |
1,336 |
| Racing against COVID-19- a vaccines strategy for Europe |
0 |
0 |
0 |
5 |
0 |
0 |
0 |
11 |
| Raising EU productivity through innovation |
0 |
0 |
1 |
27 |
2 |
5 |
10 |
22 |
| Rebooting the European Union’s Net Zero Industry Act |
0 |
0 |
3 |
11 |
0 |
3 |
8 |
26 |
| Reforming European Universities: Scope for an Evidence-Based Process |
0 |
0 |
0 |
98 |
4 |
6 |
8 |
258 |
| Remerge- regression-based record linkage with an application to PATSTAT |
0 |
0 |
1 |
63 |
3 |
6 |
8 |
121 |
| Research and innovation policies and productivity growth |
0 |
0 |
2 |
45 |
3 |
5 |
10 |
50 |
| Resultaten van de O&O-enquête bij de Vlaamse bedrijven |
0 |
0 |
0 |
2 |
0 |
2 |
3 |
38 |
| Science linkages and innovation performance: An analysis on CIS-3 firms in Belgium |
0 |
0 |
1 |
165 |
1 |
1 |
5 |
399 |
| Strategic R&D Location by Multinational Firms: Spillovers, Technology Sourcing and Competition |
0 |
0 |
1 |
262 |
1 |
1 |
5 |
814 |
| Strategic incentives for multi-national operations |
0 |
0 |
0 |
0 |
1 |
2 |
3 |
5 |
| Taste for Science, Academic Boundary Spanning and Inventive Performance of Scientists and Engineers in Industry |
0 |
0 |
0 |
28 |
1 |
1 |
2 |
64 |
| Taste for science, academic boundary spanning and inventive performance of industrial scientists and engineers |
0 |
0 |
0 |
41 |
5 |
5 |
6 |
50 |
| Technologies fly on the wings of science |
1 |
2 |
18 |
24 |
2 |
7 |
25 |
54 |
| The European Union’s growing innovation divide |
0 |
1 |
6 |
89 |
3 |
7 |
14 |
120 |
| The Great Divide in Scientific Productivity. Why the Average Scientist Does Not Exist |
0 |
0 |
0 |
16 |
3 |
6 |
7 |
126 |
| The Impact of Horizon 2020 on Innovation in Europe |
0 |
0 |
0 |
0 |
2 |
3 |
5 |
81 |
| The Lisbon Strategy and the EU's structural productivity problem |
1 |
1 |
3 |
181 |
4 |
15 |
20 |
589 |
| The Role of Information in a Duopoly Setting: Some Experimental Results |
0 |
0 |
0 |
1 |
0 |
2 |
3 |
24 |
| The World innovation landscape- Asia rising? |
0 |
0 |
0 |
93 |
7 |
9 |
9 |
116 |
| The challenge of China’s rise as a science and technology powerhouse |
0 |
0 |
0 |
121 |
2 |
5 |
8 |
130 |
| The growing digital divide in Europe and the United States |
0 |
0 |
5 |
66 |
2 |
3 |
16 |
128 |
| The growing digital divide in Europe and the United States |
0 |
0 |
1 |
55 |
2 |
6 |
9 |
133 |
| The internationalisation of the production of technology: a more complete picture for Belgium |
0 |
0 |
0 |
0 |
0 |
4 |
5 |
65 |
| The presence of non-EC multinationals in European Industry |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
| The role of information in a duopoly setting: some experimental results |
0 |
0 |
0 |
1 |
0 |
1 |
3 |
6 |
| The sensitivity of R&D investments to cash flows: Comparing young and old EU and US leading innovators |
0 |
0 |
0 |
26 |
3 |
4 |
8 |
82 |
| The sensitivity of R&D investments to cash flows: comparing young and old EU and US leading innovators |
0 |
0 |
0 |
0 |
2 |
2 |
3 |
47 |
| Top Research Productivity and its Persistence |
0 |
0 |
0 |
56 |
4 |
5 |
5 |
195 |
| Trends at the Frontier in Corporate R&D in the Digital Era: Facts, Prospects and Policies |
0 |
0 |
0 |
22 |
4 |
5 |
9 |
70 |
| Undercutting the future? European research spending in times of fiscal consolidation |
0 |
0 |
0 |
36 |
1 |
4 |
6 |
75 |
| Undertakings and Antidumping Jumping FDI in Europe |
0 |
0 |
0 |
249 |
4 |
7 |
7 |
1,168 |
| Union Wage Bargaining and European Antidumping Policy in Imperfectly Competitive Markets |
0 |
0 |
0 |
78 |
2 |
3 |
4 |
406 |
| Union wage bargaining and European antidumping policy |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Union wage bargaining and European antidumping policy |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Union wage bargaining and European antidumping policy in imperfectly competitive markets |
0 |
0 |
0 |
2 |
0 |
1 |
3 |
39 |
| Vlaams Indicatorenboek 2019 |
0 |
0 |
0 |
1 |
1 |
4 |
4 |
33 |
| Vlaams Indicatorenboek 2019 |
0 |
0 |
0 |
8 |
0 |
1 |
4 |
66 |
| When and how does education lead to economic growth? A survey with policy suggestions |
0 |
0 |
0 |
2 |
2 |
3 |
3 |
23 |
| Which firms have cooperative R&D agreements with universities? Some empirical evidence from Belgian manufacturing |
0 |
0 |
0 |
136 |
1 |
2 |
4 |
505 |
| Young Leading Innovators and EUs R&D intensity gap |
0 |
0 |
0 |
88 |
3 |
5 |
7 |
334 |
| Young Leading Innovators and the EU’s R&D intensity gap |
0 |
0 |
0 |
0 |
3 |
6 |
9 |
82 |
| Young SMEs: Driving innovation in Europe? |
0 |
0 |
0 |
78 |
3 |
7 |
8 |
89 |
| Young leading innovators and EUs R&D intensity gap |
0 |
0 |
0 |
136 |
3 |
8 |
12 |
422 |
| mRNA vaccines- a lucky shot? |
0 |
0 |
0 |
12 |
0 |
1 |
1 |
25 |
| Total Working Papers |
10 |
27 |
186 |
12,463 |
285 |
587 |
1,143 |
41,648 |
| Journal Article |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| A post-crisis policy agenda to revive Europe's Schumpeterian growth capacity |
0 |
0 |
0 |
17 |
0 |
1 |
1 |
65 |
| Alliances and the pattern of comparative advantages: a sectoral analysis |
0 |
0 |
0 |
14 |
0 |
0 |
1 |
52 |
| An Innovation-Based Industrial Policy for the EU |
0 |
0 |
0 |
0 |
5 |
5 |
13 |
13 |
| Antidumping duties, undertakings, and foreign direct investment in the EU |
0 |
0 |
0 |
112 |
4 |
5 |
10 |
329 |
| Assessing the foreign control of production of technology: The case of a small open economy |
0 |
0 |
0 |
0 |
1 |
1 |
2 |
24 |
| Assessing the potential for knowledge-based development in the transition countries of Central and Eastern Europe, the Caucasus and Central Asia |
0 |
0 |
0 |
12 |
4 |
6 |
6 |
59 |
| Bargained shares in joint ventures among asymmetric partners: Is the matthew effect catalyzing? |
0 |
0 |
0 |
28 |
0 |
1 |
3 |
108 |
| Basic science as a prescription for breakthrough inventions in the pharmaceutical industry |
0 |
0 |
0 |
9 |
2 |
6 |
7 |
87 |
| Bias against novelty in science: A cautionary tale for users of bibliometric indicators |
0 |
3 |
8 |
53 |
3 |
14 |
44 |
333 |
| Can technology lead to a competitive advantage? A case study of Flanders using european patent data |
0 |
0 |
0 |
3 |
0 |
3 |
7 |
19 |
| Coordination for EU Competitiveness |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
| Designing Contracts for University Spin‐offs |
0 |
0 |
1 |
69 |
0 |
1 |
2 |
210 |
| Differences in the rates of return to R&D for European and US young leading R&D firms |
0 |
0 |
2 |
56 |
2 |
6 |
18 |
157 |
| Direct and cross scheme effects in a research and development |
0 |
0 |
2 |
25 |
1 |
3 |
7 |
94 |
| Diversity of science linkages: A survey of innovation performance effects and some evidence from Flemish firms |
0 |
0 |
0 |
14 |
2 |
3 |
6 |
137 |
| Do science-technology interactions pay off when developing technology? |
0 |
0 |
0 |
4 |
1 |
3 |
4 |
19 |
| Domestic R&D in the presence of multinational enterprises |
0 |
0 |
0 |
119 |
1 |
1 |
2 |
284 |
| Eco-systems for young digital innovators |
0 |
0 |
0 |
8 |
1 |
1 |
3 |
42 |
| Een profiel van Vlaamse en Belgische ondernemingen binnen strategische allianties |
0 |
0 |
0 |
11 |
1 |
2 |
2 |
69 |
| Empowering the Green Innovation Machine |
0 |
0 |
0 |
7 |
2 |
2 |
3 |
45 |
| Endogenizing know-how flows through the nature of R&D investments |
0 |
0 |
1 |
70 |
0 |
3 |
5 |
285 |
| Europe's missing Yollies |
0 |
0 |
0 |
5 |
0 |
2 |
3 |
44 |
| European anti-dumping policy and the profitability of national and international collusion |
0 |
0 |
0 |
78 |
3 |
4 |
10 |
288 |
| Europe’s Path Towards the Socio-Ecological Transition |
0 |
0 |
0 |
6 |
2 |
2 |
4 |
44 |
| Foreign subsidiaries as a channel of international technology diffusion: Some direct firm level evidence from Belgium |
0 |
0 |
1 |
105 |
1 |
3 |
10 |
338 |
| Fostering the Industrial Component of the European Green Deal: Key Principles and Policy Options |
0 |
0 |
4 |
12 |
0 |
3 |
11 |
37 |
| Funding Risky Research |
0 |
0 |
0 |
10 |
8 |
10 |
13 |
35 |
| Going radical: producing and transferring disruptive innovation |
0 |
0 |
1 |
27 |
1 |
4 |
9 |
103 |
| Green Industrial Policy in Europe: Past, Present, and Prospects |
6 |
17 |
54 |
113 |
8 |
34 |
135 |
276 |
| Green tech race? The US Inflation Reduction Act and the EU Net Zero Industry Act |
0 |
5 |
76 |
124 |
9 |
27 |
150 |
231 |
| Heterogeneity in R&D cooperation strategies |
0 |
0 |
3 |
285 |
8 |
14 |
22 |
799 |
| How fast is this novel technology going to be a hit? Antecedents predicting follow-on inventions |
0 |
0 |
1 |
4 |
3 |
4 |
10 |
35 |
| Impliciete samenwerking tussen ondernemingen en prijsoorlogen: Een overzicht van de recente literatuur |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
13 |
| In Search of Complementarity in Innovation Strategy: Internal R& D and External Knowledge Acquisition |
6 |
8 |
16 |
199 |
14 |
30 |
60 |
692 |
| In search of performance effects of (in)direct industry science links |
0 |
0 |
0 |
45 |
3 |
4 |
6 |
264 |
| Innovation strategies, process and product innovations and growth: Firm-level evidence from Brazil |
0 |
1 |
2 |
99 |
0 |
5 |
14 |
420 |
| Innovative strategic groups in multinational industries |
0 |
0 |
0 |
31 |
1 |
1 |
2 |
136 |
| Insurance bargaining under risk aversion |
0 |
0 |
1 |
20 |
0 |
1 |
5 |
95 |
| Internal R & D expenditures and external technology sourcing |
0 |
1 |
3 |
384 |
2 |
5 |
15 |
1,165 |
| Licensing of university inventions: The role of a technology transfer office |
0 |
0 |
0 |
146 |
9 |
11 |
21 |
421 |
| Locational Determinants and Ranking of Host Countries: An Empirical Assessment |
0 |
0 |
0 |
6 |
2 |
4 |
7 |
24 |
| Make and buy in innovation strategies: evidence from Belgian manufacturing firms |
0 |
2 |
5 |
487 |
2 |
6 |
18 |
1,237 |
| Measuring technological novelty with patent-based indicators |
2 |
6 |
8 |
69 |
6 |
15 |
39 |
320 |
| Mind the Gap: Europe’s Early Stage Venture Capital Deficit |
0 |
0 |
0 |
0 |
1 |
1 |
2 |
51 |
| Mind the gap: Capturing value from basic research through combining mobile inventors and partnerships |
0 |
0 |
1 |
35 |
0 |
2 |
10 |
142 |
| Multinational knowledge spillovers with decentralised R&D: a game-theoretic approach |
0 |
1 |
1 |
118 |
1 |
4 |
8 |
355 |
| Not like the others: Frontier scientists for inventive performance |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Off the beaten path: what drives scientists’ entry into new fields? |
0 |
0 |
0 |
2 |
0 |
0 |
1 |
11 |
| On the design of stable joint ventures |
0 |
0 |
0 |
66 |
0 |
6 |
10 |
260 |
| On young highly innovative companies: why they matter and how (not) to policy support them |
0 |
0 |
1 |
47 |
1 |
4 |
10 |
182 |
| Organisational change and the productivity effects of green technology adoption |
0 |
0 |
1 |
30 |
3 |
5 |
11 |
151 |
| Productivity growth, R&D and the rôle of international collaborative agreements: some évidence for Belgian manufacturing companies |
1 |
1 |
2 |
91 |
1 |
1 |
3 |
705 |
| Quelles politiques pour encourager l'innovation verte ? |
0 |
0 |
1 |
5 |
0 |
0 |
2 |
47 |
| R&D Cooperation and Spillovers: Some Empirical Evidence from Belgium |
0 |
0 |
5 |
507 |
9 |
12 |
25 |
1,301 |
| R&D cooperation between firms and universities. Some empirical evidence from Belgian manufacturing |
0 |
1 |
3 |
369 |
1 |
4 |
10 |
1,004 |
| Reputation as a Mechanism Alleviating Opportunistic Host Government Behavior against MNEs |
0 |
0 |
0 |
22 |
1 |
3 |
5 |
155 |
| Reviewers are blinkered by bibliometrics |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
7 |
| Schepping en vernietiging van banen: De invloed van O&O-actieve bedrijven |
0 |
0 |
0 |
0 |
0 |
2 |
2 |
30 |
| Scientific novelty and technological impact |
0 |
0 |
1 |
38 |
1 |
8 |
15 |
201 |
| Stable R&D Cooperation with Spillovers |
0 |
0 |
0 |
7 |
2 |
4 |
4 |
15 |
| Stable R&D Cooperation with Spillovers |
0 |
0 |
0 |
0 |
1 |
1 |
2 |
468 |
| Strategic R&D Location by Multinational Firms: Spillovers, Technology Sourcing, and Competition |
0 |
0 |
0 |
75 |
10 |
11 |
14 |
278 |
| Strategic R&D Location in European Manufacturing Industries |
0 |
0 |
0 |
53 |
8 |
9 |
9 |
212 |
| Strategic investment with spillovers |
0 |
0 |
0 |
205 |
1 |
3 |
4 |
445 |
| Strategische samenwerkingsverbanden: Enkele bevindingen van Belgische partners |
0 |
0 |
1 |
1 |
0 |
0 |
2 |
19 |
| Taste for science, academic boundary spanning, and inventive performance of scientists and engineers in industry |
0 |
0 |
0 |
1 |
0 |
3 |
8 |
17 |
| Technology familiarity, recombinant novelty, and breakthrough invention |
1 |
1 |
6 |
49 |
3 |
7 |
25 |
141 |
| Technology transfer offices and commercialization of university intellectual property: performance and policy implications |
1 |
3 |
8 |
226 |
1 |
5 |
22 |
528 |
| The Green and Digital Twin Transition: EU vs US Firms |
1 |
1 |
3 |
3 |
3 |
6 |
12 |
27 |
| The Role of SMEs in Innovation in the EU. A Case for Policy Intervention? |
0 |
1 |
7 |
404 |
5 |
11 |
27 |
1,220 |
| The convergence of international and domestic markets: David Audretsch, Leo Sleuwaegen and Hideki Yamawaki, (North-Holland, Amsterdam) pp. 317 |
0 |
0 |
0 |
39 |
2 |
2 |
3 |
200 |
| The embodiment of knowledge: universities as engines of growth |
0 |
1 |
1 |
10 |
1 |
4 |
6 |
49 |
| The great divide in scientific productivity: why the average scientist does not exist |
0 |
0 |
0 |
22 |
1 |
2 |
6 |
130 |
| The impact of M&A on the R&D process: An empirical analysis of the role of technological- and market-relatedness |
1 |
5 |
14 |
293 |
2 |
12 |
55 |
871 |
| The participation of universities in technology development: do creation and use coincide? An empirical investigation on the level of national innovation systems |
0 |
0 |
0 |
18 |
1 |
4 |
6 |
92 |
| The revaluation of assets as a signalling device: a theoretical and an empirical analysis |
0 |
0 |
1 |
9 |
3 |
4 |
7 |
38 |
| The role of academic technology transfer organizations in improving industry science links |
0 |
2 |
6 |
421 |
2 |
13 |
35 |
1,195 |
| The sensitivity of R&D investments to cash flows: comparing young and old EU and US leading innovators |
0 |
0 |
1 |
14 |
5 |
9 |
15 |
95 |
| Top Research Productivity and Its Persistence: Gender as a Double-Edged Sword |
0 |
0 |
0 |
56 |
1 |
3 |
6 |
225 |
| Towards Evidence-based Reform of European Universities |
0 |
0 |
0 |
2 |
1 |
2 |
3 |
22 |
| Towards a multipolar science world: trends and impact |
0 |
0 |
0 |
1 |
1 |
2 |
3 |
17 |
| Unionization and European Antidumping Protection |
0 |
0 |
0 |
1 |
6 |
8 |
10 |
318 |
| Wage premia, price-cost margins and bargaining power in Belgian manufacturing |
0 |
0 |
0 |
20 |
0 |
4 |
7 |
85 |
| Which IP strategies do young highly innovative firms choose? |
0 |
0 |
0 |
6 |
0 |
5 |
7 |
53 |
| Which policy instruments to induce clean innovating? |
2 |
2 |
5 |
139 |
7 |
12 |
18 |
384 |
| Why Firms (Do Not) Participate in EU Funded R&D Consortia |
0 |
0 |
0 |
0 |
1 |
2 |
4 |
48 |
| Young SMEs as a Motor of Europe’s Innovation Machine |
0 |
0 |
0 |
3 |
2 |
3 |
8 |
31 |
| Young leading innovators and the EU's R&D intensity gap |
0 |
0 |
1 |
51 |
0 |
2 |
12 |
166 |
| Übernahmen in der Pharmaindustrie: Fokus mehr auf Innovationsmärkte als auf Marktverdrängung richten |
0 |
0 |
1 |
1 |
0 |
0 |
2 |
6 |
| Total Journal Articles |
21 |
62 |
260 |
6,346 |
202 |
462 |
1,169 |
21,446 |
LogEc is hosted by the
Örebro University School of Business.